Photodynamic therapy for age-related macular degeneration treatment: Epidemiological and clinical analysis of a long-term study

Ophthalmic Surgery Lasers and Imaging

Volumn 40, Issue 3, 2009, Pages 277-284

  Mataix, Jorge ^a,b   Carmen Desco, M ^a   Palacios, Elena ^a   Garcia Pous, Maria ^a   Navea, Amparo ^a  

^a Fundacion Oftalmologica del Mediterraneo   (Spain)

^b NONE   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTICLE; CLINICAL TRIAL; CONTROLLED STUDY; FEMALE; FLUORESCENCE ANGIOGRAPHY; HUMAN; MAJOR CLINICAL STUDY; MALE; PHOTODYNAMIC THERAPY; PRIORITY JOURNAL; RETINA MACULA AGE RELATED DEGENERATION; SUBRETINAL NEOVASCULARIZATION; TREATMENT RESPONSE; VISION; VISUAL ACUITY;

AGED; AGED, 80 AND OVER; CHOROIDAL NEOVASCULARIZATION; FEMALE; FLUORESCEIN ANGIOGRAPHY; FOLLOW-UP STUDIES; HUMANS; MACULAR DEGENERATION; MALE; MIDDLE AGED; PHOTOCHEMOTHERAPY; PHOTOSENSITIZING AGENTS; PORPHYRINS; PROSPECTIVE STUDIES; SPAIN; TREATMENT OUTCOME; VISION DISORDERS; VISUAL ACUITY;

EID: 67149120616     PISSN: 15428877     EISSN: None     Source Type: Journal    
DOI: 10.3928/15428877-20090430-09     Document Type: Article

References (22)

1. Bressler NM, Bressler SB, Fine SL. Age-related macular degeneration. Surv Ophthalmol. 1988;32:375-413. (Pubitemid 18169353)
2. Gass JD. Drusen and disciform macular detachment and degeneration. Arch Ophthalmol. 1973;90:206-217.
3. Gass JD. Pathogenesis of disciform detachment of the neuroepithelium. Am J Ophthalmol. 1967;63(suppl):1-139.
4. Treatment of Age-Related Macular Degeneration With Photodynamic Therapy (TAP) Study Group. Photodynamic therapy of subfoveal choroidal neovascularization in age-related macular degeneration with verteporfin: one-year results of 2 randomized clinical trials. TAP report. Arch Ophthalmol. 1999;117:1329-1345. Erratum in: Arch Ophthalmol. 2000;118:488.
5. Bressler NM; Treatment of Age-Related Macular Degeneration with Photodynamic Therapy (TAP) Study Group. Photodynamic therapy of subfoveal choroidal neovascularization in age-related macular degeneration with verteporfin: two-year results of 2 randomized clinical trials. TAP Report No. 2. Arch Ophthalmol. 2001;119:198-207.
6. Bressler NM, Arnold J, Benchaboune M, et al. Verteporfin therapy of subfoveal choroidal neovascularization in patients with age-related macular degeneration: additional information regarding baseline lesion composition's impact on vision outcomes. TAP Report No. 3. Arch Ophthalmol. 2002;120:1443-1454.
7. Bressler NM, Bressler SB, Haynes LA, et al. Verteporfin therapy for subfoveal choroidal neovascularization in age-related macular degeneration: four-year results of an open-label extension of 2 randomized clinical trials. TAP Report No. 7. Arch Ophthalmol. 2005;123:1283-1285.
8. Kaiser PK; Treatment of Age-related Macular Degeneration with Photodynamic Therapy (TAP) Study Group. Verteporfin therapy of subfoveal choroidal neovascularization in age-related macular degeneration: 5-year results of two randomized clinical trials with an open-label extension. TAP Report No. 8. Graefes Arch Clin Exp Ophthalmol. 2006;244:1132-1142.
9. Azab M, Boyer DS, Bressler NM, et al. Verteporfin therapy of subfoveal minimally classic choroidal neovascularization in age-related macular degeneration: 2-year results of a randomized clinical trial. Arch Ophthalmol. 2005;123:448-457. (Pubitemid 40489914)
10. Verteporfin In Photodynamic Therapy Study Group. Verteporfin therapy of subfoveal choroidal neovascularization in age-related macular degeneration: two-year results of a randomized clinical trial including lesions with occult with no classic choroidal neovascularization. Verteporfin in Photodynamic Therapy Report No. 2. Am J Ophthalmol. 2001;131:541-560. (Pubitemid 32427660)
11. Blinder KJ, Bradley S, Bressler NM, et al. Effect of lesion size, visual acuity, and lesion composition on visual acuity change with and without verteporfin therapy for choroidal neovascularization secondary to age-related macular degeneration. TAP and VIP Report No. 1. Am J Ophthalmol. 2003;136:407-418. (Pubitemid 37101236)
12. Holz FG, Jorzik J, Schutt F, Flach U, Unnebrink K. Agreement among ophthalmologists in evaluating fluorescein angiograms in patients with neovascular age-related macular degeneration for photodynamic therapy eligibility (FLAP-study). Ophthalmology. 2003;110:400-405. (Pubitemid 36184347)
13. Margheiro RR, Margheiro AR, DeSantis ME. Laser treatments with verteporfin therapy and its potential impact on retinal practices. Retina. 2000;20:325-330.
14. Pauleikhoff D, Radermacher M, Spital G, et al. Visual prognosis of second eyes in patients with unilateral late exudative age-related macular degeneration. Graefes Arch Clin Exp Ophthalmol. 2002;240:539-542. (Pubitemid 36097081)
15. Frennesson CI. Photodynamic therapy with verteporfin in patients with age related macular degeneration and juxtafoveal choroidal neovascularization. Acta Ophthalmol Scand. 2004;82:651-655. (Pubitemid 40057773)
16. Frennesson CI, Nilsson SE. Encouraging results of photodynamic therapy with Visudyne in a clinical patient material of age-related macular degeneration. Acta Ophthalmol Scand. 2004;82:645-650. (Pubitemid 40057772)
17. Essex RW, Qureshi SH, Cain MS, Harper CA, Guymer RH. Photodynamic therapy in practice: a review of the results of the first 12 months experience with verteporfin at the Royal Victorian Eye and Ear Hospital. Clin Experiment Ophthalmol. 2003;31:476-481. (Pubitemid 38049223)
18. Axer-Siegel R, Ehrlich R, Yassur Y, et al. Photodynamic therapy for age related macular degeneration in a clinical setting: visual results and angiographic patterns. Am J Ophthalmol. 2004;137:258-264. (Pubitemid 38220997)
19. Olsen TW, Feng X, Kasper TJ, Rath PP, Steuer ER. Fluorescein angiography lesion type frequency in neovascular age-related macular degeneration. Ophthalmology. 2004;11:250-255. (Pubitemid 38183223)
20. Atmaca LS, Batioglu F, Atmaca P. Evaluation of choroidal neovascularization in age-related macular degeneration with fluorescein and indocyanine green videoangiography. Ophthalmologica. 1996;210:148-151. (Pubitemid 26155114)
21. Zawinka C, Ergun E, Stur M. Prevalence of patients presenting with neovascular age-related macular degeneration in an urban population. Retina. 2005;25:324-331. (Pubitemid 40517362)
22. Stevens TS, Bressler NM, Maguire MG, et al. Occult choroidal neovascularization in age-related macular degeneration: a natural history study. Arch Ophthalmol. 1997;115:345-350. (Pubitemid 27131300)